Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > I guess my tactic is all wrong ...

<< Previous

Bullboard Posts

Next >>

Post by MrMugsyon Dec 02, 2021 10:00am

269 Views

Post# 34189540

I guess my tactic is all wrong ...

I'm going to have to write more often here and get the ignored haters to really work on their bashing skills amongst themselves.

That's what happens when you buy high and now you're stuck with the shares you were hoping to turn over quickly. Now you're deep in a hole and you don't see any way out. What do you do? You go after others who you see as "pumpers."

All good - I have strategies for times like this and I can wait. You obviously can't and it eats you guys up inside.

: )

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks